Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors.
Ingenerf M, Auernhammer C, Lorbeer R, Winkelmann M, Mansournia S, Mansour N, Hesse N, Heinrich K, Ricke J, Berger F, Schmid-Tannwald C. Ingenerf M, et al. Radiol Oncol. 2024 Apr 14. doi: 10.2478/raon-2024-0024. Online ahead of print. Radiol Oncol. 2024. PMID: 38613843 Free article.
Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S, Seidensticker R, Seidensticker M, Ricke J, Schinner R, Treitl K, Rübenthaler J, Ingenerf M, Schmid-Tannwald C. Karim S, et al. Among authors: ingenerf m. Radiol Oncol. 2024 Feb 21;58(1):33-42. doi: 10.2478/raon-2024-0017. eCollection 2024 Mar 1. Radiol Oncol. 2024. PMID: 38378033 Free PMC article.
Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy.
Winkelmann M, Blumenberg V, Rejeski K, Quell C, Bücklein V, Ingenerf M, Unterrainer M, Schmidt C, Dekorsy FJ, Bartenstein P, Ricke J, von Bergwelt-Baildon M, Subklewe M, Kunz WG. Winkelmann M, et al. Among authors: ingenerf m. J Immunother Cancer. 2023 Oct;11(10):e006659. doi: 10.1136/jitc-2022-006659. J Immunother Cancer. 2023. PMID: 37880181 Free PMC article.
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy.
Winkelmann M, Blumenberg V, Rejeski K, Quell C, Bücklein VL, Ingenerf M, Unterrainer M, Schmidt C, Dekorsy FJ, Bartenstein P, Ricke J, von Bergwelt-Baildon M, Subklewe M, Kunz WG. Winkelmann M, et al. Among authors: ingenerf m. Ann Hematol. 2024 Jan;103(1):259-268. doi: 10.1007/s00277-023-05507-9. Epub 2023 Oct 20. Ann Hematol. 2024. PMID: 37861736
Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor-PET/CT.
Ingenerf M, Rübenthaler J, Wenter V, Zacherl M, Völter F, Winkelmann M, Karim H, Schinner R, Ricke J, Berger F, Schmid-Tannwald C. Ingenerf M, et al. Front Oncol. 2023 Aug 15;13:1194152. doi: 10.3389/fonc.2023.1194152. eCollection 2023. Front Oncol. 2023. PMID: 37655102 Free PMC article.
Diffusion-weighted imaging in Crohn's disease.
Ingenerf M, Schmid-Tannwald C. Ingenerf M, et al. Radiologie (Heidelb). 2023 Nov;63(Suppl 2):27-33. doi: 10.1007/s00117-023-01191-y. Epub 2023 Aug 21. Radiologie (Heidelb). 2023. PMID: 37603068 Review. English.
Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT.
Ingenerf M, Grawe F, Winkelmann M, Karim H, Ruebenthaler J, Fabritius MP, Ricke J, Seidensticker R, Auernhammer CJ, Zacherl MJ, Seidensticker M, Schmid-Tannwald C. Ingenerf M, et al. Diagn Interv Imaging. 2024 Jan;105(1):15-25. doi: 10.1016/j.diii.2023.06.007. Epub 2023 Jul 13. Diagn Interv Imaging. 2024. PMID: 37453859
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria.
Winkelmann M, Blumenberg V, Rejeski K, Bücklein VL, Ingenerf M, Unterrainer M, Schmidt C, Dekorsy FJ, Bartenstein P, Ricke J, von Bergwelt-Baildon M, Subklewe M, Kunz WG. Winkelmann M, et al. Among authors: ingenerf m. Cancer Imaging. 2023 May 15;23(1):44. doi: 10.1186/s40644-023-00566-7. Cancer Imaging. 2023. PMID: 37189191 Free PMC article.
19 results